AnGes Inc (AMGXF)
0.3353
0.00 (0.00%)
USD |
OTCM |
May 01, 16:00
AnGes Revenue (TTM): 1.075M for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.075M |
| September 30, 2023 | 0.8841M |
| June 30, 2023 | 0.6295M |
| March 31, 2023 | 0.5046M |
| December 31, 2022 | 0.5113M |
| September 30, 2022 | 0.5339M |
| June 30, 2022 | 0.6272M |
| March 31, 2022 | 0.6053M |
| December 31, 2021 | 0.5818M |
| September 30, 2021 | 0.5205M |
| June 30, 2021 | 0.4344M |
| March 31, 2021 | 0.4322M |
| December 31, 2020 | 0.3758M |
| September 30, 2020 | 0.2901M |
| June 30, 2020 | 1.593M |
| March 31, 2020 | 2.372M |
| December 31, 2019 | 3.006M |
| September 30, 2019 | 5.940M |
| June 30, 2019 | 5.429M |
| March 31, 2019 | 5.484M |
| December 31, 2018 | 5.478M |
| September 30, 2018 | 3.491M |
| June 30, 2018 | 3.367M |
| March 31, 2018 | 3.203M |
| December 31, 2017 | 3.255M |
| Date | Value |
|---|---|
| September 30, 2017 | 4.646M |
| June 30, 2017 | 4.715M |
| March 31, 2017 | 4.744M |
| December 31, 2016 | 4.733M |
| September 30, 2016 | 3.275M |
| June 30, 2016 | 3.083M |
| March 31, 2016 | 3.587M |
| December 31, 2015 | 3.552M |
| September 30, 2015 | 8.138M |
| June 30, 2015 | 8.518M |
| March 31, 2015 | 8.111M |
| December 31, 2014 | 8.228M |
| September 30, 2014 | 3.731M |
| June 30, 2014 | 3.471M |
| March 31, 2014 | 4.486M |
| December 31, 2013 | 5.050M |
| September 30, 2013 | 5.069M |
| June 30, 2013 | 5.232M |
| March 31, 2013 | 6.065M |
| December 31, 2012 | 5.560M |
| September 30, 2012 | 5.403M |
| June 30, 2012 | 5.151M |
| March 31, 2012 | 3.058M |
| December 31, 2011 | 3.053M |
| September 30, 2011 | 3.400M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
0.2901M
Minimum
Sep 2020
5.940M
Maximum
Sep 2019
1.387M
Average
0.6053M
Median
Mar 2022
Revenue (TTM) Benchmarks
| Takeda Pharmaceutical Co Ltd | 29.70B |
| Nxera Pharma Co Ltd | 88.33M |
| PeptiDream Inc | 202.69M |
| Stemcell Holdings Inc | 9.984M |
| Healios KK | 0.8776M |